Research Shows CBG Destroys Gastrointestinal Cancer Cells

Numerous studies have concluded that gastrointestinal cancers are among the most widespread causes of cancer-related deaths worldwide. This is exactly why the Maryland-based Cannabics Pharmaceuticals Inc. conducted its own experiments involving two hemp extracts, cannabigerol (CBG) and cannabichromene (CBC), proving that they can, in fact, successfully destroy Gastrointestinal Cancer Cells (GCC) in humans. Upon announcing … Continue reading Research Shows CBG Destroys Gastrointestinal Cancer Cells